Literature DB >> 8656142

Cardiovascular risk groups and mortality in an urban swedish male population: the Malmö Preventive Project.

G Berglund1, K F Eriksson, B Israelsson, T Kjellström, F Lindgärde, I Mattiasson, J A Nilsson, L Stavenow.   

Abstract

OBJECTIVES: To describe the size, overlap and mortality of four cardiovascular risk groups, in order to give a scientific background for the prevention of cardiovascular disease in a representative urban population.
SETTING: Section of Preventive Medicine, Department of Medicine, Malmö University Hospital, Malmö, Sweden.
SUBJECTS: Between 1974 and 1984 22444 men born between 1949 and 1921, constituting 75% of the total male population in these age groups, took part in a comprehensive screening examination aimed at detecting risk factors for cardiovascular disease.
INTERVENTIONS: Those at high-risk of developing cardiovascular disease were referred to their general practitioner or to special clinics for hypertension, hyperlipidaemia and diabetes. The follow-up, which lasted until the end of 1991, averaged 12.2 years. MAIN OUTCOME MEASURES: Total death (n = 1450) and death from ischaemic heart disease (IHD) (n = 471).
RESULTS: Hypertension was found in 13%, hypercholesterolaemia in 19% and diabetes mellitus in 2.6% of the subjects; 49% of the subjects smoked. Multiple risk factors were found in over 17% of the total cohort. Despite the intervention, all-cause mortality during follow-up was increased three-fold in smokers and in men with hypercholesterolaemia, four-fold in hypertensive men and five-fold in men with diabetes, compared to men with no risk factors. The vast majority of deaths (81%) occurred in men who smoked, had hypertension or had high serum cholesterol. Ischaemic heart disease (IHD) was increased five-fold in smokers, seven-fold in men with hypercholesterolaemia, nine-fold in hypertensive men and 12-fold in men with diabetes. Again, the vast majority of IHD deaths (86%) occurred in the first three categories. Combinations of risk factors substantially increased total mortality as well as IHD mortality.
CONCLUSIONS: The large proportion (64%) of the population with risk factors for cardiovascular disease and the substantially (5-12-fold) increased IHD mortality in those risk groups, calls for actions aimed at preventing premature IHD deaths. Such action should include measures directed towards the whole population and comprehensive treatment programmes for high-risk individuals, including intervention to stop smoking. The substantial overlap between risk factors calls for one high-risk clinic caring for all risk groups.

Entities:  

Mesh:

Year:  1996        PMID: 8656142     DOI: 10.1046/j.1365-2796.1996.483819000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  31 in total

1.  A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the Bone Scan Index.

Authors:  David Ulmert; Reza Kaboteh; Josef J Fox; Caroline Savage; Michael J Evans; Hans Lilja; Per-Anders Abrahamsson; Thomas Björk; Axel Gerdtsson; Anders Bjartell; Peter Gjertsson; Peter Höglund; Milan Lomsky; Mattias Ohlsson; Jens Richter; May Sadik; Michael J Morris; Howard I Scher; Karl Sjöstrand; Alice Yu; Madis Suurküla; Lars Edenbrandt; Steven M Larson
Journal:  Eur Urol       Date:  2012-01-27       Impact factor: 20.096

2.  Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women.

Authors:  A H Holmberg; O Johnell; P M Nilsson; J Nilsson; G Berglund; K Akesson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

3.  Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts.

Authors:  Tanja Stocks; Kilian Rapp; Tone Bjørge; Jonas Manjer; Hanno Ulmer; Randi Selmer; Annekatrin Lukanova; Dorthe Johansen; Hans Concin; Steinar Tretli; Göran Hallmans; Håkan Jonsson; Pär Stattin
Journal:  PLoS Med       Date:  2009-12-22       Impact factor: 11.069

4.  Risk factors for hip fractures in a middle-aged population: a study of 33,000 men and women.

Authors:  Anna H Holmberg; Olof Johnell; Peter M Nilsson; Jan-Ake Nilsson; Göran Berglund; Kristina Akesson
Journal:  Osteoporos Int       Date:  2005-09-22       Impact factor: 4.507

5.  Marital status and occupation in relation to short-term case fatality after a first coronary event--a population based cohort.

Authors:  Sofia Gerward; Patrik Tydén; Gunnar Engström; Bo Hedblad
Journal:  BMC Public Health       Date:  2010-05-10       Impact factor: 3.295

6.  Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.

Authors:  Björn Nodin; Nooreldin Zendehrokh; Jenny Brändstedt; Elise Nilsson; Jonas Manjer; Donal J Brennan; Karin Jirström
Journal:  J Ovarian Res       Date:  2010-06-17       Impact factor: 4.234

7.  Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.

Authors:  Asa Ehlén; Donal J Brennan; Björn Nodin; Darran P O'Connor; Jakob Eberhard; Maria Alvarado-Kristensson; Ian B Jeffrey; Jonas Manjer; Jenny Brändstedt; Mathias Uhlén; Fredrik Pontén; Karin Jirström
Journal:  J Transl Med       Date:  2010-08-20       Impact factor: 5.531

8.  Long-term temporal trends in cardiovascular and metabolic risk factors.

Authors:  Wegene Borena; Tanja Stocks; Susanne Strohmaier; Alexander Strasak; Jonas Manjer; Dorthe Johansen; Håkan Jonsson; Kilian Rapp; Hans Concin; Göran Hallmans; Pär Stattin; Hanno Ulmer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project).

Authors:  Artur Fedorowski; Lars Stavenow; Bo Hedblad; Göran Berglund; Peter M Nilsson; Olle Melander
Journal:  Eur Heart J       Date:  2009-08-20       Impact factor: 29.983

10.  Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can).

Authors:  Tanja Stocks; Wegene Borena; Susanne Strohmaier; Tone Bjørge; Jonas Manjer; Anders Engeland; Dorthe Johansen; Randi Selmer; Göran Hallmans; Kilian Rapp; Hans Concin; Håkan Jonsson; Hanno Ulmer; Pär Stattin
Journal:  Int J Epidemiol       Date:  2009-04-20       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.